What Enzyme tokenizes
Enzyme (MLN) is a real-world-asset (RWA) / tokenization token, currently ranked 365th by market capitalization among the assets we track. Enzyme is tied to the tokenization of real-world assets, one of crypto's fastest-growing narratives. Rather than a purely native asset, it represents or governs claims linked to instruments that exist off-chain.
Enzyme (MLN) is a decentralized finance platform allowing users to create and manage their own investment strategies on the Ethereum blockchain. It aims to simplify and automate asset management for both individuals and institutions.
How tokenized assets work
Value here comes from connecting on-chain capital to off-chain returns. The structures are improving fast, but Enzyme still rides on the credibility of the institutions issuing and custodying the underlying.
MLN is not mined; it is issued as a token rather than secured by its own mining or staking layer.
Background & fundamentals
Enzyme operates under a centralized structure, which concentrates protocol decisions in an identifiable issuer or foundation. A documented core team of 13 contributors is listed publicly, a depth of disclosed staffing many long-tail tokens lack. Its codebase is open-source, meaning the implementation can be audited rather than taken on trust.
The project publishes a whitepaper documenting its original design, which is worth reading before sizing any position in MLN. In sector terms it is most often filed under Smart Contracts, Exchange, and Ethereum (ETH) Token (ERC-20).
Where Enzyme sits in the market
At $2.11, Enzyme carries a market capitalization of $5.62M. Around $5.48M changes hands across exchanges in a typical 24-hour window. That is a turnover of about 97.62% of the float — unusually high, the kind of churn that accompanies major news or speculative spikes.
Enzyme carries no fixed maximum supply; issuance follows a programmatic schedule rather than a hard cap. MLN remains -99% beneath its all-time high of $270.05, the kind of gap that historically takes a full cycle or a fresh catalyst to close. Measured from its all-time low of $1.57, MLN is up +34%.
What the price history shows
Recent moves read 24-hour -0.78%, 7-day -31.99%, 30-day -33.12%, 1-year -75.35%. Across roughly the last 365 days of daily candles, MLN endured a peak-to-trough drawdown of about 88% before stabilizing.
Volatility profile
Recent action puts Enzyme in the Extreme-volatility band — it is in a high-volatility regime — these are the conditions where outsized gains and losses both become more likely. Over the last 30 days the move totals -33.12%, a useful input for stop placement and position sizing.
How to evaluate an RWA token like Enzyme
For an asset of this type, three lenses matter most:
- Underlying assets — what real-world instruments back or relate to MLN, and their credit quality.
- Legal enforceability — whether the on-chain claim is actually backed by enforceable off-chain rights.
- Adoption — how much real capital and how many institutions are using the platform behind MLN.
This page pulls live market data, on-chain stats where available, exchange-by-exchange volume, and our forecast model into one view so you can work through those questions in a single place. None of it is investment advice — it is a structured starting point for your own research.